Cargando…
The epigenetic aging, obesity, and lifestyle
The prevalence of obesity has dramatically increased worldwide over the past decades. Aging-related chronic conditions, such as type 2 diabetes and cardiovascular disease, are more prevalent in individuals with obesity, thus reducing their lifespan. Epigenetic clocks, the new metrics of biological a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514048/ https://www.ncbi.nlm.nih.gov/pubmed/36176280 http://dx.doi.org/10.3389/fcell.2022.985274 |
_version_ | 1784798193735696384 |
---|---|
author | Franzago, Marica Pilenzi, Lucrezia Di Rado, Sara Vitacolonna, Ester Stuppia, Liborio |
author_facet | Franzago, Marica Pilenzi, Lucrezia Di Rado, Sara Vitacolonna, Ester Stuppia, Liborio |
author_sort | Franzago, Marica |
collection | PubMed |
description | The prevalence of obesity has dramatically increased worldwide over the past decades. Aging-related chronic conditions, such as type 2 diabetes and cardiovascular disease, are more prevalent in individuals with obesity, thus reducing their lifespan. Epigenetic clocks, the new metrics of biological age based on DNA methylation patterns, could be considered a reflection of the state of one’s health. Several environmental exposures and lifestyle factors can induce epigenetic aging accelerations, including obesity, thus leading to an increased risk of age-related diseases. The insight into the complex link between obesity and aging might have significant implications for the promotion of health and the mitigation of future disease risk. The present narrative review takes into account the interaction between epigenetic aging and obesity, suggesting that epigenome may be an intriguing target for age-related physiological changes and that its modification could influence aging and prolong a healthy lifespan. Therefore, we have focused on DNA methylation age as a clinical biomarker, as well as on the potential reversal of epigenetic age using a personalized diet- and lifestyle-based intervention. |
format | Online Article Text |
id | pubmed-9514048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95140482022-09-28 The epigenetic aging, obesity, and lifestyle Franzago, Marica Pilenzi, Lucrezia Di Rado, Sara Vitacolonna, Ester Stuppia, Liborio Front Cell Dev Biol Cell and Developmental Biology The prevalence of obesity has dramatically increased worldwide over the past decades. Aging-related chronic conditions, such as type 2 diabetes and cardiovascular disease, are more prevalent in individuals with obesity, thus reducing their lifespan. Epigenetic clocks, the new metrics of biological age based on DNA methylation patterns, could be considered a reflection of the state of one’s health. Several environmental exposures and lifestyle factors can induce epigenetic aging accelerations, including obesity, thus leading to an increased risk of age-related diseases. The insight into the complex link between obesity and aging might have significant implications for the promotion of health and the mitigation of future disease risk. The present narrative review takes into account the interaction between epigenetic aging and obesity, suggesting that epigenome may be an intriguing target for age-related physiological changes and that its modification could influence aging and prolong a healthy lifespan. Therefore, we have focused on DNA methylation age as a clinical biomarker, as well as on the potential reversal of epigenetic age using a personalized diet- and lifestyle-based intervention. Frontiers Media S.A. 2022-09-13 /pmc/articles/PMC9514048/ /pubmed/36176280 http://dx.doi.org/10.3389/fcell.2022.985274 Text en Copyright © 2022 Franzago, Pilenzi, Di Rado, Vitacolonna and Stuppia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Franzago, Marica Pilenzi, Lucrezia Di Rado, Sara Vitacolonna, Ester Stuppia, Liborio The epigenetic aging, obesity, and lifestyle |
title | The epigenetic aging, obesity, and lifestyle |
title_full | The epigenetic aging, obesity, and lifestyle |
title_fullStr | The epigenetic aging, obesity, and lifestyle |
title_full_unstemmed | The epigenetic aging, obesity, and lifestyle |
title_short | The epigenetic aging, obesity, and lifestyle |
title_sort | epigenetic aging, obesity, and lifestyle |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514048/ https://www.ncbi.nlm.nih.gov/pubmed/36176280 http://dx.doi.org/10.3389/fcell.2022.985274 |
work_keys_str_mv | AT franzagomarica theepigeneticagingobesityandlifestyle AT pilenzilucrezia theepigeneticagingobesityandlifestyle AT diradosara theepigeneticagingobesityandlifestyle AT vitacolonnaester theepigeneticagingobesityandlifestyle AT stuppialiborio theepigeneticagingobesityandlifestyle AT franzagomarica epigeneticagingobesityandlifestyle AT pilenzilucrezia epigeneticagingobesityandlifestyle AT diradosara epigeneticagingobesityandlifestyle AT vitacolonnaester epigeneticagingobesityandlifestyle AT stuppialiborio epigeneticagingobesityandlifestyle |